Stock comparison

CIvsMCK

Cigna GroupvsMcKesson Corp. Real data pulled from the alphactor.ai fundamentals pipeline — valuation, balance-sheet health, momentum, and analyst sentiment side by side.

CI

Cigna Group

$279.72

+1.31%

Health Care$71.2BNYSE
MCK

McKesson Corp

$836.1

+3.67%

Health Care$108.3BNYSE

60-day price, rebased to 100

CI +2.05% · MCK -1.23%

Round-by-round

CI 4·MCK 2
EdgeCI

Valuation upside

+961.30% vs +529.30% to DCF fair value

EdgeMCK

Balance-sheet strength

Altman Z 2.53 vs 6.07

EdgeCI

Fundamental quality

Piotroski 7.00 vs 3.00 (of 9)

EdgeCI

Growth + margins

Rule-of-40 15.50 vs 1.50

EdgeCI

60-day momentum

+2.05% vs -1.23% price return

EdgeMCK

Market-cap liquidity

$71.2B vs $108.3B

Verdict

Across6categories,CItakes the edge with4wins to2. Neither score is a buy signal on its own: run the full backtest and credibility tests on alphactor.ai before putting money on it.

Backtest a strategy onCIorMCK

Point-in-time backtests, 8-layer credibility pipeline, conviction scoring — free to start.

For informational and educational purposes only. Not financial advice. Learn more